Table 4.
Mean and standard deviation as well as the difference between the mean of drug evaluation indices before and after the intervention in the studied groups
| Drugs | Index | I2 | Begg and mazumdar rank correlation test | Mean ± SD before intervention (drug group) | Mean ± SD after intervention (drug group) | Mean difference and standard deviation before and after the intervention |
|---|---|---|---|---|---|---|
| Mycophenolate | MG-ADL | 85.3 | 1.000 | 5.9 ± 0.87 | 7.5 ± 4.09 | 1.4 ± 0.9 |
| SFEMG | 0 | – | 71.5 ± 11.3 | 60.5 ± 13.1 | 0.9 ± 0.56 | |
| Anti-AChR antibodies | 79.1 | – | 11.1 ± 2.1 | 5.5 ± 2.4 | 1.9 ± 1.5 | |
| QMGS | 67.9 | 0.734 | 12.3 ± 0.71 | 8.1 ± 0.59 | 1.4 ± 0.77 | |
| Immunoglobulin or plasma exchange | MG-ADL | 78.5 | 1.000 | 8.2 ± 1.3 | 4.4 ± 0.84 | 1.3 ± 0.63 |
| SFEMG | 43.5 | 1.000 | 82.2 ± 1.43 | 54.5 ± 27.5 | 1.5 ± 0.73 | |
| Anti-AChR antibodies | 99.8 | 1.000 | 10.8 ± 4.6 | 52.7 ± 34.1 | –2.006 ± 0.78 | |
| QMGS | 98.6 | 0.391 | 11.2 ± 1.6 | 9.4 ± 1.8 | 0.62 ± 0.28 | |
| Corticosteroids | QMGS | 99.4 | – | 7.08 ± 1.09 | 5.9 ± 2.2 | 1.64 ± 1.6 |